Literature DB >> 23512841

Gastrointestinal hormones and bariatric surgery-induced weight loss.

Viorica Ionut1, Miguel Burch, Adrienne Youdim, Richard N Bergman.   

Abstract

UNLABELLED: Obesity continues to be a major public health problem in the United States and worldwide. While recent statistics have demonstrated that obesity rates have begun to plateau, more severe classes of obesity are accelerating at a faster pace with important implications in regards to treatment. Bariatric surgery has a profound and durable effect on weight loss, being to date one of the most successful interventions for obesity.
OBJECTIVE: To provide updates to the possible role of gut hormones in post bariatric surgery weight loss and weight loss maintenance. DESIGN AND METHODS: The current review examines the changes in gastro-intestinal hormones with bariatric surgery and the potential mechanisms by which these changes could result in decreased weight and adiposity.
RESULTS: The mechanism by which bariatric surgery results in body weight changes is incompletely elucidated, but it clearly goes beyond caloric restriction and malabsorption.
CONCLUSION: Changes in gastro-intestinal hormones, including increases in GLP-1, PYY, and oxyntomodulin, decreases in GIP and ghrelin, or the combined action of all these hormones might play a role in induction and long-term maintenance of weight loss.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512841      PMCID: PMC4423817          DOI: 10.1002/oby.20364

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  80 in total

1.  Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass.

Authors:  Rachel Horta Freire; Mariane Curado Borges; Jacqueline Isaura Alvarez-Leite; Maria Isabel Toulson Davisson Correia
Journal:  Nutrition       Date:  2011-08-31       Impact factor: 4.008

2.  Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.

Authors:  Samuel Klein; Elisa Fabbrini; Bruce W Patterson; Kenneth S Polonsky; Carlos A Schiavon; Jose L Correa; Joao E Salles; Bernardo L Wajchenberg; Ricardo Cohen
Journal:  Obesity (Silver Spring)       Date:  2012-01-19       Impact factor: 5.002

3.  Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism.

Authors:  Andrew C Shin; Huiyuan Zheng; Hans-Rudolf Berthoud
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

4.  Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model.

Authors:  J Kampe; A Stefanidis; S H Lockie; W A Brown; J B Dixon; A Odoi; S J Spencer; J Raven; B J Oldfield
Journal:  Int J Obes (Lond)       Date:  2012-03-27       Impact factor: 5.095

5.  Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

Authors:  Ricardo Cohen; Pedro Paulo Caravatto; Jose Luis Correa; Patricia Noujaim; Tarissa Zanata Petry; João Eduardo Salles; Carlos Aurelio Schiavon
Journal:  Surg Obes Relat Dis       Date:  2012-02-02       Impact factor: 4.734

Review 6.  A review of late-stage CNS drug candidates for the treatment of obesity.

Authors:  D J Heal; J Gosden; S L Smith
Journal:  Int J Obes (Lond)       Date:  2012-03-13       Impact factor: 5.095

7.  Short-term effects of sleeve gastrectomy and caloric restriction on blood pressure in diet-induced obese rats.

Authors:  Amaia Rodríguez; Sara Becerril; Víctor Valentí; Rafael Moncada; Leire Méndez-Giménez; Beatriz Ramírez; Andoni Lancha; Marina Martín; María A Burrell; Victoria Catalán; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Obes Surg       Date:  2012-09       Impact factor: 4.129

8.  Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients.

Authors:  Philippe Topart; Guillaume Becouarn; Patrick Ritz
Journal:  Surg Obes Relat Dis       Date:  2012-03-03       Impact factor: 4.734

9.  The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control.

Authors:  Dimitri J Pournaras; Clare Glicksman; Royce P Vincent; Shophia Kuganolipava; Jamie Alaghband-Zadeh; David Mahon; Jan H R Bekker; Mohammad A Ghatei; Stephen R Bloom; Julian R F Walters; Richard Welbourn; Carel W le Roux
Journal:  Endocrinology       Date:  2012-06-06       Impact factor: 4.736

10.  Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

Authors:  Stavros N Karamanakos; Konstantinos Vagenas; Fotis Kalfarentzos; Theodore K Alexandrides
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

View more
  41 in total

Review 1.  Prevention of Weight Regain Following Bariatric Surgery.

Authors:  Robert F Kushner; Kirsten Webb Sorensen
Journal:  Curr Obes Rep       Date:  2015-06

Review 2.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

3.  Relationship Between Diet and Body Composition After Biliopancreatic Diversion.

Authors:  Alicia Calleja-Fernández; Begoña Pintor-de-la-Maza; Rubén Diez-Rodríguez; Alfonso Vidal-Casariego; Ana Urioste-Fondo; Isidoro Cano-Rodríguez; María D Ballesteros-Pomar
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

4.  MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study.

Authors:  Philip D Ambery; Sebastian Klammt; Maximillian G Posch; Marcella Petrone; Wenji Pu; Cristina Rondinone; Lutz Jermutus; Boaz Hirshberg
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

Review 5.  Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections?

Authors:  Chen Liu; Syann Lee; Joel K Elmquist
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

6.  A Novel Full Sense Device to Treat Obesity in a Porcine Model: Preliminary Results.

Authors:  Jung-Hoon Park; Nader Bakheet; Hee Kyong Na; Jae Yong Jeon; Sung Hwan Yoon; Kun Yung Kim; Wang Zhe; Do Hoon Kim; Hwoon-Yong Jung; Ho-Young Song
Journal:  Obes Surg       Date:  2019-05       Impact factor: 4.129

Review 7.  Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.

Authors:  Mohsen Mazidi; Pedro Paulo P de Caravatto; John R Speakman; Ricardo V Cohen
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

8.  Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

Authors:  Antonella Maffei; Ann Marie Segal; Juan Carlos Alvarez-Perez; Adolfo Garcia-Ocaña; Paul E Harris
Journal:  Mol Endocrinol       Date:  2015-03-09

9.  Fasting Circulating Glicentin Increases After Bariatric Surgery.

Authors:  Juliette Raffort; Patricia Panaïa-Ferrari; Fabien Lareyre; Pascale Bayer; Pascal Staccini; Patrick Fénichel; Giulia Chinetti
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

10.  A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.

Authors:  Brian Finan; Bin Yang; Nickki Ottaway; David L Smiley; Tao Ma; Christoffer Clemmensen; Joe Chabenne; Lianshan Zhang; Kirk M Habegger; Katrin Fischer; Jonathan E Campbell; Darleen Sandoval; Randy J Seeley; Konrad Bleicher; Sabine Uhles; William Riboulet; Jürgen Funk; Cornelia Hertel; Sara Belli; Elena Sebokova; Karin Conde-Knape; Anish Konkar; Daniel J Drucker; Vasily Gelfanov; Paul T Pfluger; Timo D Müller; Diego Perez-Tilve; Richard D DiMarchi; Matthias H Tschöp
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.